Deals
Mylan Investors Vote to Push Ahead With Hostile Perrigo Deal
- Two-thirds of votes cast were in favor of pursuing takeover
- Tender offer for Perrigo shares must be initiated by Sept. 14
This article is for subscribers only.
Mylan NV’s shareholders voted in favor of moving forward with a $33 billion hostile bid for over-the-counter drugmaker Perrigo Co., putting the fate of the deal in Perrigo investors’ hands.
The proposal gained the support of two-thirds of votes cast, representing more than half of all outstanding shares, Mylan said in a statement on Friday. Mylan will take its formal offer directly to Perrigo shareholders in “coming weeks,” Mylan Chairman Robert J. Coury said.